Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized

The first and only All-in-one subscription platform offering all of your PR Distribution and Media Outreach Tools in one single solution. Monthly & Annual Subscriptions.

Find & create journalist lists with the most up to date database in the industry.

Personalize and customize your pitch for maximum engagement.

Discover your brand, industry, and competitor mentions.

Now you can track every mention, every conversation, and every shift in sentiment — all from the platform you're already using.

Turn your PR data into actionable intelligence with comprehensive reporting and analytics on every campaign.

Catch issues before our editors do. ACCESS Verified gives you a real-time first pass on your press release so you can submit with confidence — every time.

The first and only All-in-one subscription platform that offers you the ability to manage all of your IR communications needs from a single source. Explore our IR subscriptions

Explore how you can upgrade your IR Site today.

Ensure your IR Site is accessible for your entire audience.

Experience seamless calls with our dedicated team of domestic operators.

Easily send your releases out with quick turnarounds and no extra fees.

Host your day knowing you've got the most experienced webcast team in the industry.

Provide a secure and confidential reporting channel to protect your organization and employees.

Streamline your PR & IR needs with one platform.

Easily schedule and manage your investor meetings with our comprehensive and easy to use software.

Our PR and IR tools are designed to meet all necessary regulatory requirements, giving you the confidence to communicate effectively and compliantly. Streamline your communications needs today with our one-stop shop offering.

Whether a startup or established brand, we deliver the support, targeted distribution, media outreach, and flexible pricing & payment options needed to amplify your story with confidence.

We simplify the process of delivering success for both you and your clients. We understand the importance of getting it right, equipping you with seamless billing, flexible plans and payment structures, and clear reporting and analytics to ensure every campaign runs smoothly and achieves measurable results.

We understand the need to manage high volume of press release distribution efficiently. That's why we offer a dedicated API designed specifically for our legal customers, delivering a streamlined, simple process that ensures value and ease at every step.

We understand the importance of cost efficiency for high-volume partners, which is why we offer bulk discounts tailored to meet your needs while maximizing value.

Designed for brands that need help consistently fueling their content strategy and calendar with optimized press releases, blogs, and more…

Tailored for brands with a solid content strategy seeking support for effectively reaching and engaging the media.

Made for brands that need more comprehensive support building and managing their content strategy, media outreach and engagement plan.

Personalized support to optimize your platform, including tailored journalist list creation, pitch guidance, and monitoring setup.

Continual support and management including ongoing list creation, pitch creation and modifications, monitoring adjustments, and additional reporting and analytics review.

Press Release creation and optimization for SEO and audience engagement

Back to the Newsroom Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized Wednesday, 11 November 2026 09:30 AM

CHICAGO, IL / ACCESS Newswire / November 11, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") ( NASDAQ:COSM ), a diversified, vertically integrated global healthcare group, today announced that its U.S. direct-to-consumer subscription business reached $1,832,785 in monthly subscription value as of October 31, 2026, equivalent to approximately $22.0 million on an annualized basis. In October 2026, the Company's U.S. e-commerce business recorded total sales of $1,673,004, of which $1,015,231 was attributable to subscriptions.

Cosmos Health launched its U.S. subscription model in mid-July 2026 and began scaling it in mid-September. The Company's products are sold through its own online stores directly to customers, who can choose a subscription for recurring delivery at checkout. Active subscriptions renew on a recurring basis, so every new subscriber can represent an ongoing customer relationship rather than a single sale.

The Company has allocated an increased marketing budget to continue scaling its U.S. direct-to-consumer sales through the fourth quarter of 2026, including the holiday shopping season. Cosmos Health plans to expand digital customer acquisition, grow its subscription base and introduce additional products from its portfolio to its U.S. online stores. Momentum has continued into November, with U.S. e-commerce sales continuing to grow significantly.

Greg Siokas, CEO of Cosmos Health, stated: "Since we began scaling our U.S. subscription platform in mid-September, we have built a subscription business with $1.83 million in monthly subscription value, or approximately $22 million on an annualized basis. As of October 31, more than 12,500 subscriptions were active, with an average of approximately 2.4 products per subscription.

"We believe recurring revenue is among the most valuable revenue a consumer health company can build, and we plan to continue scaling our U.S. direct-to-consumer business through the fourth quarter and beyond."

Cosmos Health Inc. (NASDAQ:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .

With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans," and similar expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could," generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company's control, including, but not limited to: the Company's ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine and ongoing conflicts in the Middle East and other regions on the Company's business, operations, and the economy in general; the Company's ability to successfully develop and commercialize its proprietary products and technologies; the timing, execution, regulatory clearance, valuation, structuring, and completion of any potential asset-backed or tokenized financing program; the legal, regulatory, and technological risks associated with digital assets and blockchain-based financial structures; the conversion of contract manufacturing pipeline volumes into production and revenue, including the timing, volume and terms of orders placed under multi-year agreements; the realization of anticipated gross margins; the timing, cost and completion of planned capital investments; changes in interest rates; changes in foreign currency exchange rates, commodity or other price inflation and deflation; our ability to issue debt on terms and at rates acceptable to us; the impact and expected outcome of investigations, inquiries, claims, and litigation; the challenges of operating in international markets; the adequacy of insurance coverage; the effect of accounting charges and of adopting certain accounting standards; the impact of legal and regulatory changes, including changes to tax laws and regulations; guidance for fiscal 2026 and beyond and financial outlook. Forward-looking statements are based on currently available information and our current assumptions, expectations and projections about future events. You should not rely on our forward-looking statements. These statements are not guarantees of future performance and are subject to future events, risks and uncertainties - many of which are beyond our control, dependent on the actions of third parties, or currently unknown to us - as well as potentially inaccurate assumptions that could cause actual results to differ materially from our historical experience and our expectations and projections. These risks and uncertainties include, but are not limited to, those described from time to time in our periodic reports filed with the SEC and available at the SEC's website ( www.sec.gov ). There also may be other factors that we cannot anticipate or that are not described herein, generally because we do not currently perceive them to be material. Such factors could cause results to differ materially from our expectations. Forward-looking statements speak only as of the date they are made, and we do not undertake to update these statements other than as required by law. You are advised, however, to review any further disclosures we make on related subjects in our filings with the Securities and Exchange Commission and in our other public statements.

Note: All figures are preliminary, unaudited operating data from the Company's e-commerce and subscription platforms and may differ from amounts in its financial statements. Total sales include taxes and shipping, net of discounts, returns and fees. Monthly subscription value is the amount billable on active subscriptions in a month at standard renewal pricing as of October 31, 2026; the annualized figure is that value multiplied by twelve and is not a forecast. Subscription metrics are subject to cancellations and churn, and none of these metrics represent U.S. GAAP revenue. November statements reflect preliminary data; actual results may differ materially.